1192 related articles for article (PubMed ID: 16083502)
1. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review.
Utian WH
Health Qual Life Outcomes; 2005 Aug; 3():47. PubMed ID: 16083502
[TBL] [Abstract][Full Text] [Related]
2. Menopausal hot flushes and night sweats: where are we now?
Archer DF; Sturdee DW; Baber R; de Villiers TJ; Pines A; Freedman RR; Gompel A; Hickey M; Hunter MS; Lobo RA; Lumsden MA; MacLennan AH; Maki P; Palacios S; Shah D; Villaseca P; Warren M
Climacteric; 2011 Oct; 14(5):515-28. PubMed ID: 21848495
[TBL] [Abstract][Full Text] [Related]
3. Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stages.
Deecher DC; Dorries K
Arch Womens Ment Health; 2007; 10(6):247-57. PubMed ID: 18074100
[TBL] [Abstract][Full Text] [Related]
4. Vasomotor symptoms in menopause: physiologic condition and central nervous system approaches to treatment.
Rapkin AJ
Am J Obstet Gynecol; 2007 Feb; 196(2):97-106. PubMed ID: 17306645
[TBL] [Abstract][Full Text] [Related]
5. An International Menopause Society study of climate, altitude, temperature (IMS-CAT) and vasomotor symptoms in urban Indian regions.
Stefanopoulou E; Shah D; Shah R; Gupta P; Sturdee DW; Hunter MS
Climacteric; 2014 Aug; 17(4):417-24. PubMed ID: 24099134
[TBL] [Abstract][Full Text] [Related]
6. Vasomotor symptoms in menopause: where we've been and where we're going.
Pinkerton JV; Zion AS
J Womens Health (Larchmt); 2006 Mar; 15(2):135-45. PubMed ID: 16536677
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life of women with menopausal hot flushes and night sweats.
Ayers B; Hunter MS
Climacteric; 2013 Apr; 16(2):235-9. PubMed ID: 22809134
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with resilience or vulnerability to hot flushes and night sweats during the menopausal transition.
Duffy OK; Iversen L; Aucott L; Hannaford PC
Menopause; 2013 Apr; 20(4):383-92. PubMed ID: 23250082
[TBL] [Abstract][Full Text] [Related]
9. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2004; 11(1):11-33. PubMed ID: 14716179
[TBL] [Abstract][Full Text] [Related]
10. IMS study of climate, altitude, temperature and vasomotor symptoms in the United Arab Emirates.
Stefanopoulou E; Gupta P; Mostafa RM; Nosair N; Mirghani Z; Moustafa K; Al Kusayer G; Sturdee DW; Hunter MS
Climacteric; 2014 Aug; 17(4):425-32. PubMed ID: 24625187
[TBL] [Abstract][Full Text] [Related]
11. Vasomotor symptoms and cardiovascular disease risk.
Pines A
Climacteric; 2011 Oct; 14(5):535-6. PubMed ID: 21848496
[TBL] [Abstract][Full Text] [Related]
12. An overview of menopause associated vasomotor symptoms and options available in its management.
Okeke TC; Ezenyeaku CC; Ikeako LC; Agu PU
Niger J Med; 2013; 22(1):7-14. PubMed ID: 23441513
[TBL] [Abstract][Full Text] [Related]
13. Managing Hot Flushes in Menopausal Women: A Review.
Mallhi TH; Khan YH; Khan AH; Mahmood Q; Khalid SH; Saleem M
J Coll Physicians Surg Pak; 2018 Jun; 28(6):460-465. PubMed ID: 29848424
[TBL] [Abstract][Full Text] [Related]
14. MF-101, an estrogen receptor beta agonist for the treatment of vasomotor symptoms in peri- and postmenopausal women.
Stovall DW; Pinkerton JV
Curr Opin Investig Drugs; 2009 Apr; 10(4):365-71. PubMed ID: 19337958
[TBL] [Abstract][Full Text] [Related]
15. Perceived control, lifestyle, health, socio-demographic factors and menopause: impact on hot flashes and night sweats.
Pimenta F; Leal I; Maroco J; Ramos C
Maturitas; 2011 Aug; 69(4):338-42. PubMed ID: 21680119
[TBL] [Abstract][Full Text] [Related]
16. Adiposity and reporting of vasomotor symptoms among midlife women: the study of women's health across the nation.
Thurston RC; Sowers MR; Chang Y; Sternfeld B; Gold EB; Johnston JM; Matthews KA
Am J Epidemiol; 2008 Jan; 167(1):78-85. PubMed ID: 17881385
[TBL] [Abstract][Full Text] [Related]
17. Hot flushes and night sweats are associated with coronary heart disease risk in midlife: a longitudinal study.
Herber-Gast G; Brown WJ; Mishra GD
BJOG; 2015 Oct; 122(11):1560-7. PubMed ID: 25377022
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness of sublingual and topical compounded bioidentical hormone replacement therapy in postmenopausal women: an observational cohort study.
Ruiz AD; Daniels KR
Int J Pharm Compd; 2014; 18(1):70-7. PubMed ID: 24881343
[TBL] [Abstract][Full Text] [Related]
19. Undertreatment of menopausal symptoms and novel options for comprehensive management.
Lewis V
Curr Med Res Opin; 2009 Nov; 25(11):2689-98. PubMed ID: 19775194
[TBL] [Abstract][Full Text] [Related]
20. Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States.
Williams RE; Kalilani L; DiBenedetti DB; Zhou X; Granger AL; Fehnel SE; Levine KB; Jordan J; Clark RV
Climacteric; 2008 Feb; 11(1):32-43. PubMed ID: 18202963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
